Hikma reiterates full year guidance following good start to the year - Middle East Business News and Information
Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting.
Riad Mishlawi, Hikma's CEO, said:
'We are pleased to reiterate our Group guidance for 2025. As a global company with strong local expertise and footprint, we are leveraging our manufacturing proficiency and advanced technologies to meet the needs of our customers and patients across our markets. Looking ahead, and recognising the broader geo-political challenges, we are well-positioned. Our step up in R&D investment, alongside local manufacturing enhancements, and strategic partnerships will continue to strengthen our portfolio and pipeline and ensure sustained success.'
Injectables
Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies. We are seeing strong demand for our products across our European and MENA markets, where we continue to launch new products. In North America we are benefitting from good demand for the recently launched liraglutide injection and the contribution from the newly acquired Xellia portfolio. This is helping to offset increased competition across some of our existing higher margin products.
We expect momentum to improve in the second half driven by new product launches and contract manufacturing. We are making excellent progress in the enhancements to our Bedford, Ohio facility, which will significantly increase our US-based injectables manufacturing capacity.
We continue to expect 2025 Injectables revenue to grow in the range of 7% to 9%. Phasing and mix of sales will impact margins in the first half but we continue to expect full year core operating margin to be in the mid-30s.
Branded
Our Branded business is performing well. We continue to make good progress in building our diversified portfolio of products used to treat chronic illnesses, with a focus on oncology and lifestyle diseases, supported by our global expertise and strong local market position.
Our leading presence in the MENA region, combined with the breadth of our reach and strong commercial capabilities positions us as a partner of choice. We recently signed an exclusive licensing agreement with pharmaand GmbH, a global pharmaceutical business based in Vienna, to commercialise rucaparib, an innovative small-molecule oral oncology therapy, across the MENA region. This is in line with our strategy to be a leading provider of oncology medicines in the region.
We continue to expect 2025 Branded revenue to grow in the range of 6% to 7% in constant currency, with core EBIT margin close to 25%.
Generics
In our Generics business we are seeing solid demand across our differentiated portfolio, particularly for our nasal and inhalation products. By focusing on reliability of supply, high service levels and leveraging our US manufacturing facility, we are successfully securing longer-term customer awards.
We continue to strengthen our R&D capabilities, including building a team in our new Zagreb, Croatia R&D centre, and are progressing with key development projects that will help strengthen our portfolio and pipeline for the medium to long-term. We are progressing well preparing our Columbus facility to accommodate our recently announced contract manufacturing partnership, and we are seeing increasing demand for our high-quality US-based manufacturing services.
We continue to expect Generics revenue to be broadly flat in 2025 with core operating margin of around 16%.
International trade policies
We are confident that our significant and expanding US manufacturing footprint, which supplies the majority of our US sales, combined with our focus on quality and reliability of supply, positions us well and underpins our resilience in the current environment. We do import some finished products into the US as well as capital equipment, and we have a diversified global supply chain for our raw and packaging materials, including active pharmaceutical ingredients (API).
Full year outlook unchanged
We continue to expect Group revenue to grow in the range of 4% to 6% and for core operating profit to be in the range of $730 million to $770 million in 2025. Group core operating profit growth, which is around 4% at the midpoint of guidance, will be weighted to the second half. We are monitoring the evolving tariff backdrop and will look to remain agile in responding to both opportunities and impacts where possible, but have not reflected an impact from tariffs in our full year outlook.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CairoScene
26 minutes ago
- CairoScene
Progressio's Plan to Power Egypt's Economy Through Invention
Spearheaded by Progressio, 1 Million Minds is reimagining innovation in Egypt by fostering inventors and creating the infrastructure to turn local ideas into global industries. Progressio's movement isn't chasing hype. It's building a new economic engine - by spotlighting inventors, commercializing IP, and fixing the innovation supply chain from the inside out. Egypt's next wave of growth won't come from logistics apps or fintech plays—at least not if Progressio has anything to say about it. The Cairo-based technology R&D firm is leading a bold new initiative called 1 Million Minds, a movement designed not to fund the next startup, but to foster the next inventor. It's not just a branding distinction. It's a philosophy. 'Entrepreneurs are already being supported in Egypt. What we've never properly invested in are the inventors,' says Yoeil Ashraf, founder and CEO of Progressio. 'Those who build new things. Those who innovate at the core product level. 1 Million Minds is here to change that.' A Movement, Not a Center At its heart, 1 Million Minds isn't a campaign, an incubator, or even a government program. It's a national movement—founded and spearheaded by Progressio—meant to embed invention, R&D, and intellectual property into the cultural and economic DNA of Egypt. Rather than chase venture funding or quick exits, OMM is focused on long-term impact. It's building public platforms, storytelling pipelines, educational programs, and incentive models that bring inventors out of the shadows and into the center of national development. Its founding belief is simple: if inventors are supported—technically, financially, and emotionally—they will build the products that solve Egypt's biggest problems, and ultimately fuel unprecedented economic growth. Why Inventors, Why Now? Egypt has no shortage of bright minds. But without visibility, protection, or infrastructure, most innovations never make it past the prototype stage. 'We're not short on talent,' Yoeil says. 'We're short on systems that recognize and reward invention.' Progressio sees a gap in how innovation is defined and supported. Entrepreneurs are coached to pitch and scale, but inventors—those working in materials science, med-tech, food engineering, and software IP—often lack access to legal frameworks, commercialization support, or even cultural recognition. OMM's goal is to flip that script. The KPIs of a Movement This isn't about inspiration alone. 1 Million Minds is built on measurable inflection points. Progressio has identified three historic benchmarks it's working toward: 1. The first Egyptian millionaire inventor, through royalties generated from licensed IP 2. The first startup to secure investment or acquisition based on intellectual property alone 3. The first corporate R&D investment into a locally developed invention These aren't hypotheticals. Progressio is building the support systems—legal, educational, media, and financial—to make them real. Beyond Inspiration: Building Infrastructure OMM's strategy operates across multiple verticals: * Education and awareness, demystifying IP law, R&D, and commercialization * Cultural storytelling, positioning inventors as national heroes through awards, documentaries, and public events * Community building, with mentorship programs and regional bootcamps * Visibility and recognition, turning invention into something aspirational, not obscure 'We believe that if we create an environment where inventors are incentivized, rewarded, and integrated into our innovation supply chain, we won't just fix our economic problems—we'll redefine what growth looks like for Egypt,' Yoeil says. A Parallel Track: The NCTC While 1 Million Minds takes the cultural and community lead, another Progressio-led initiative will provide the technical backbone. Launching in mid-2025, the National Center for Technology Commercialization (NCTC) is a separate but complementary project. Designed as a national platform for tech transfer and commercialization, the NCTC will focus on IP protection, licensing support, startup assistance, and industry collaboration—particularly in sectors like agriculture, energy, healthcare, and IT. The NCTC is where invention will be translated into viable business. 1 Million Minds is where invention becomes a national cause. Fixing the Chain, Fueling the Future Skeptics may ask whether a country can really build an innovation economy on invention alone. Progressio's bet is that it can—if invention is supported systemically, not sporadically. And in a region where innovation is often imported or licensed in, OMM offers a different thesis: that Egypt has the raw intellectual firepower to lead, not just follow, and that if that power is unlocked at scale, the results won't just be social—they'll be seismic. 'This isn't a campaign,' Yoeil says. 'It's a new foundation for how we grow.'
CairoScene
a day ago
- CairoScene
How a Dubai-Based Palestinian Brand Bottles Heritage
How a Dubai-Based Palestinian Brand Bottles Heritage At some point in our diaspora timelines- between explaining where we're really from, passport queues and WhatsApp voice notes about political heartbreak- we begin hoarding things that taste like home. Fragrant spices in ziploc bags. Date syrup and honey in repurposed jam jars. That one specific za'atar or sumac mix your cousin swears by. It's not a habit. It's survival. Isra Abu Zayed, the Palestinian-Canadian academic and storyteller, wearing her heritage like the keffiyeh draped over her grandmother's shoulder, knows this ache. But unlike most of us who stash bottles of olive oil between our socks on the way back from Amman or Beirut, she decided to build a business around it. For Isra Abu Zayed, home has always been a matter of the palate rather than the postcode. Growing up in Toronto, she might have sat at a kitchen table far from the olive groves of the West Bank, but every Friday morning wafts of za'atar-dusty bread, the sweet stickiness of knafeh and, most of all, the green-gold glimmer of olive oil were reminders of a place she never really saw, but always knew. 'I'm Palestinian through and through,' Isra tells SceneNowUAE 'My parents made sure our identity shaped every part of how we moved through the world.' Schoolyard taunts and classroom maps couldn't erase the stories they shared at home- tales of harvests, of farmers who tended trees older than most nations, of olive-pressed rituals handed down through it wasn't until her six year old daughter wanted to learn more about her heritage and share that- 'a bottle of that season's oil for her teacher'- that Isra realised how tangible that connection could become. And just like that, a bottle of olive oil turned into a passport. In 2021, out of that realisation, Zeit Bladi came into being. From a single family-run farm in the West Bank, where Nabali trees can take twenty years to bear their first fruit, the olives are hand-picked only when village elders decree they're ready. They are cold-pressed within hours of harvest, then travel by land through Jordan to Dubai, arriving as spring's first bottles: limited seasonal drops that turn anticipation into ritual. 'We only sell what the land gives us each season,' Isra explains. 'It's not about scale; it's about honouring history, community and resilience- one small bottle at a time.'
See - Sada Elbalad
a day ago
- See - Sada Elbalad
ECB Cut Interest Rates by 25 basis-point to 2.00%
Taarek Refaat The European Central Bank (ECB) announced Thursday an interest rate cut by 25 basis points to the interest rate of deposit facility to 2%, down from its highest level in mid-2023 of 4%. 'The decision to cut the deposit facility interest rate – the rate at which the Board directs monetary policy – is based on its updated assessment of inflation expectations, the dynamics of core inflation, and the strength of the impact of monetary policy,' the European Central Bank said in a statement. The eurozone's inflation rate fell below the European Central Bank's target of 2% in May, recording 1.9%, a lower-than-expected level, according to preliminary data released earlier this week. However, economic growth continued to slow even as interest rates eased. The latest estimates show that the eurozone expanded by 0.3% in the first quarter of 2025. The central bank's decision comes at a critical time for the eurozone economy, as companies and policymakers face growing uncertainty in the wake of escalating geopolitical tensions. According to CNBC, the European stock markets closed higher after the ECB's decision to cut rates by 25 basis points. 'The Stoxx Europe 600 index closed up 0.9%, the U.K.'s FTSE 100 rose by 0.1% and Germany's DAX was higher by 0.2%. Meanwhile, France's CAC 40 was the only major benchmark to fall 0.2%,' CNBC wrote. US President Donald Trump's tariff policy is a major concern, as tariffs are expected to significantly affect economic growth. Certain sector-specific tariffs could severely damage Europe, where key industries such as steel and automobiles are affected. read more CBE: Deposits in Local Currency Hit EGP 5.25 Trillion Morocco Plans to Spend $1 Billion to Mitigate Drought Effect Gov't Approves Final Version of State Ownership Policy Document Egypt's Economy Expected to Grow 5% by the end of 2022/23- Minister Qatar Agrees to Supply Germany with LNG for 15 Years Business Oil Prices Descend amid Anticipation of Additional US Strategic Petroleum Reserves Business Suez Canal Records $704 Million, Historically Highest Monthly Revenue Business Egypt's Stock Exchange Earns EGP 4.9 Billion on Tuesday Business Wheat delivery season commences on April 15 News China Launches Largest Ever Aircraft Carrier Sports Former Al Zamalek Player Ibrahim Shika Passes away after Long Battle with Cancer Sports Neymar Announced for Brazil's Preliminary List for 2026 FIFA World Cup Qualifiers News Prime Minister Moustafa Madbouly Inaugurates Two Indian Companies Arts & Culture New Archaeological Discovery from 26th Dynasty Uncovered in Karnak Temple Business Fear & Greed Index Plummets to Lowest Level Ever Recorded amid Global Trade War Arts & Culture Zahi Hawass: Claims of Columns Beneath the Pyramid of Khafre Are Lies News Flights suspended at Port Sudan Airport after Drone Attacks News Shell Unveils Cost-Cutting, LNG Growth Plan Videos & Features Video: Trending Lifestyle TikToker Valeria Márquez Shot Dead during Live Stream
